Nasser H. Hanna is a board-certified internal medicine physician who works with malignant pleural mesothelioma patients.
- Noted for strong research focus.
- Ongoing research includes exploration of epidermal growth factor receptor inhibition, anti-angiogenesis, cell-cycle inhibitors, and novel chemotherapeutic agents.
- Participating in several ongoing clinical trials of chemotherapy drugs, such as one designed to test the effects of experimental EC145 given alone or in combination with docetaxel.
- Teaches at Indiana University School of Medicine.
Education:
- M.D. degree from University of Missouri, Columbia Medical School.